[{"NetIncomeLossConverted_4_FY_USD":2711647000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":263106000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":263396000.0,"CommonStockSharesConverted_0_FY_shares":259890000.0,"Assets_0_FY_USD":11751808000.0,"RevenuesConverted_1_FY_USD":1627820000.0,"RevenuesConverted_4_FY_USD":6205683000.0,"EarningsPerShareBasic_4_FY_USD":10.44,"CommonStockSharesOutstanding_0_FY_shares":259890000.0,"EarningsPerShareDiluted_1_FY_USD":2.3,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":3253505000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":259841000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":260038000.0,"StockholdersEquityConverted_0_FY_USD":8686815000.0,"NetIncomeLossConverted_1_FY_USD":604190000.0,"EarningsPerShareDiluted_4_FY_USD":10.29,"EarningsPerShareBasic_1_FY_USD":2.32,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20201231","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20210211"}]